Want to join the conversation?
On April 21, 2016, $JCI announced that it expects 3Q16 earnings from continuing operations, excluding certain items, to be $1.01-1.04 per diluted share. The company also raised its full year guidance to $3.85-4.00 per diluted share, excluding certain items.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?